Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 23, 2025
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.
Journal: European urology
Published: September 26, 2025
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationale.
Journal: Future oncology (London, England)
Published: June 23, 2025
E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors-design and rationale.
Journal: Future oncology (London, England)
Published: May 27, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.
Journal: European urology
Published: April 22, 2025
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: March 27, 2025
A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale.
Journal: Future oncology (London, England)
Published: March 21, 2025
Fiducial tracking fidelity in robotic prostate SBRT: a comparison of a 3-fraction boost following pelvic nodal irradiation and definitive 5-fraction treatment.
Journal: Radiation oncology (London, England)
Published: December 02, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Journal: The New England journal of medicine
Published: September 16, 2024
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial.
Journal: Nature cancer
Published: August 15, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2024
Last Updated: 09/26/2026